SKYE seeks to end BGP deal

SkyePharma (SKYE; LSE:SKP) said it notified Bioglan (LSE:BGP) that it seeks to terminate their deal for SKYE's Solaraze non-steroidal anti-inflammatory drug diclofenac to treat actinic keratosis, unde...